A carregar...
CK2 and PI(3)K are direct molecular targets of quercetin in chronic lymphocytic leukaemia
Despite the encouraging results of the innovative therapeutic treatments, complete remission is uncommon in patients affected by chronic lymphocytic leukaemia, which remains an essentially incurable disease. Recently, clinical trials based on BH3-mimetic drugs showed positive outcomes in subjects wi...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5522089/ https://ncbi.nlm.nih.gov/pubmed/28489572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17246 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|